Staphylococcus aureus, a successful pathogen;Staphylococcus aureus, een succesvolle ziekteverwekker

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 22, 2003, Pages 1045-1048

  Van Den Broek, P J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCIDIN; METICILLIN; VANCOMYCIN;

ABSCESS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; ENDOCARDITIS; FOOD POISONING; GENE; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NETHERLANDS; NONHUMAN; OSTEOMYELITIS; PNEUMONIA; PVL GENE; REVIEW; SCANDINAVIA; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; WOUND INFECTION;

ADAPTATION, PHYSIOLOGICAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; GENOME, BACTERIAL; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 0037969733     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Pasteur L. De l'extension de la théorie des germes á l'étiologie de quelque maladies communes. CR Acad Sci (Paris) 1880;90:1033-44.
2. Ogston A. Report upon micro-organisms in surgical diseases. BMJ 1881;1:369-75.
3. Rosenbach FJ. Mikro-organismen bei den Wund-infections-krankheiten des Menschen. Wiesbaden: Bergmann; 1884.
4. Kirby W. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 1944;99:452-3.
5. Salgado CD, Farr BM, Calfée DP. Community-acquired methicillinresistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
6. Jessen O, Rosendal K, Bulow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med 1969;281:627-35.
7. Jevons MP. 'Celbenin'-resistant staphylococci. BMJ 1961;1:124-5.
8. Wu SW, Lencastre H de, Tomasz A. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J Bacteriol 2001;183:2417-24.
9. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687-92.
10. Oliveira DC, Tomasz A, De Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180-9.
11. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
12. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogenously resistant to vancomycin. Lancet 1997;350:1670-3.
13. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001;1:147-55.
14. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
15. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002;51:902.
16. Moran GJ, Mount J. Update on emerging infections: news from the Centers for Disease Control and Prevention. Ann Emerg Med 2003;41:148-51.
17. González-Zorn B, Courvalin P. VanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect Dis 2003;3:67-8.
18. Flier M van der, Dijk NB van, Fluit AC, Fleer A, Wolfs TFW, Gestel JPJ van. Fatale pneumonie bij een adolescent door thuis opgelopen meticillineresistente Staphylococcus aureus positief voor Panton-Valentine-leukocidine. Ned Tijdschr Geneeskd 2003;147:1076-9.
19. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian group on antimicrobial resistance. Lancet 1998;352:145-6.
20. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999;282:1123-5.
21. Prévost G, Couppié P, Prévost P, Gayet S, Petiau P, Cribier B, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995;42:237-45.
22. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-32.
23. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359:753-9.
24. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002;35:819-24.
25. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001;357:1225-40.